Yu Yong 4
4 · GENELUX Corp · Filed Dec 20, 2024
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Yu Yong
VP, Clinical Trial Operations
Transactions
- Award
Stock Option (right to buy)
2024-12-18+39,000→ 39,000 totalExercise: $2.29Exp: 2034-12-17→ Common Stock (39,000 underlying) - Award
Common Stock
2024-12-18+29,000→ 39,869 total
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. 25% of the RSUs vest on August 1, 2025, and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.
- [F2]25% of the shares vest on August 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter.